Summary
Mucopolysaccharidosis IVA (MPS IVA; Morquio A disease) is a lysosomal storage disorder caused by deficiency of N-acetylgalactosamine-6-sulfate sulfatase. The natural history of this disease is incompletely understood. To study which variables influence the clinical outcome, we conducted a study in which MPS IVA patients were asked to fill out a questionnaire with inquiries regarding family history, diagnosis, signs and symptoms, height, weight, surgical history, physical activity, and general complaints. A total of 326 patients (172 male, 154 female) from 42 countries enrolled in the Morquio A Registry programme. The mean age of patients enrolled was 14.9 years for males and 19.1 years for females, with a wide range of 1–73 years. Sixty-four per cent of the patients were under 18 years. Initial symptoms were recognized between 1 and 3 years of age (mean age 2.1 years) and mean age at diagnosis for the patients was 4.7 years. A progressive skeletal dysplasia was commonly observed among the MPS IVA patients. Fifty per cent of patients underwent surgical operations to improve their quality of life. The most frequent surgical sites include neck (51%), ear (33%), leg (26%) and hip (25%). The birth length for affected males and females was 52.2 ± 4.7 cm and 52.2 ± 4.5 cm, respectively. The final adult height for affected males and females was 122.5 ± 22.5 cm and 116.5 ± 20.5 cm, respectively. The results of this study provide a reference for assessment of efficacy for studies of novel therapies.
Similar content being viewed by others
Abbreviations
- C6S:
-
chondroitin 6-sulfate
- DS:
-
dermatan sulfate
- ERT:
-
enzyme replacement therapy
- GAG:
-
glycosaminoglycans
- GalNAc:
-
N-acetylgalactosamine
- GALNS:
-
GalNAc 6-sulfate sulfatase
- HS:
-
heparan sulfate
- IMO:
-
International Morquio Organization
- KS:
-
keratan sulfate
- MPS IVA:
-
mucopolysaccharidosis IVA (Morquio A disease)
References
Applegarth DA, Toone JR, Lowry RB (2000) Incidence of inborn errors of metabolism in British Columbia. Pediatrics 105 :e10.
Dorfman A, Arbogast B, Matalon R (1976) The enzymic defects in Morquio and Maroteaux-Lamy syndrome. Adv Exp Med Biol 68: 261–276.
Fukuda S, Tomatsu S, Masue M, et al (1992) Mucopolysaccharidosis type IVA: N-acetylgalactosamine-6-sulfate sulfatase exonic point mutations in classical Morquio and mild cases. J Clin Invest 90: 1049–1053.
Glossl J, Kresse H (1982) Impaired degradation of keratan sulphate by Morquio A fibroblasts. Biochem J 203: 335–338.
Hori T, Tomatsu S, Nakashima Y, et al (1995) Mucopolysaccharidosis type IVA: common double deletion at the N-acetylgalactosamine-6-sulfate sulfatase gene. Genomics 26: 535–542.
Kato Z, Fukuda S, Tomatsu S, et al (1997) A novel common missense mutation G301C in the N-acetylgalactosamine-6-sulfate sulfatase gene in mucopolysaccharidosis IVA. Hum Genet 101: 97–101.
Lowry RB, Applegarth DA, Toone JR, et al (1990) An update on the frequency of mucopolysaccharide syndromes in British Columbia. Hum Genet 85: 389–390.
Meikle PJ, Hopwood JJ, Clague AE, et al (1999) Prevalence of lysosomal storage disorders. JAMA 281: 249–254.
Montaño AM, Yamagishi A, Tomatsu S, et al (2000) The mouse N-acetylgalactosamine-6-sulfate sulfatase (Galns) gene: cDNA isolation, genomic characterization, chromosomal assignment and analysis of the 5′-flanking region. Biochim Biophys Acta 1500: 323–334.
Montaño AM, Kaitila I, Sukegawa K, et al (2003) Mucopolysaccharidosis IVA: characterization of a common mutation found in Finnish patients with attenuated phenotype. Hum Genet 113: 162–169.
Morquio L (1929) Sur une forme de dystrophie osseuse familiale. Bull Soc Pediat Paris 27: 145–152.
Nakashima Y, Tomatsu S, Hori T, et al (1994) Mucopolysaccharidosis IVA: molecular cloning of the human N-acetylgalactosamine 6-sulfatase (GALNS) gene and analysis of the 5′-flanking region. Genomics 20: 99–104.
Nelson J (1997) Incidence of the mucopolysaccharidoses in Northern Ireland. Hum Genet 101:355–358.
Northover H, Cowie RA, Wraith JE (1996) Mucopolysaccharidosis type IVA (Morquio syndrome): a clinical review. J Inherit Metab Dis 19: 357–365.
Ogawa T, Tomatsu S, Fukuda S, et al (1995) Mucopolysaccharidosis IVA: screening and identification of mutations of the N-acetyl galactosamine-6-sulfate sulfatase gene. Hum Mol Genet 4: 341–349.
Pinto R, Caseiro C, Lemos M, et al (2004) Prevalence of lysosomal storage diseases in Portugal. Eur J Hum Genet 12: 87–92.
Poorthuis BJ, Wevers RA, Kleijer WJ, et al (1999) The frequency of lysosomal storage diseases in The Netherlands. Hum Genet 105: 151–156.
Sukegawa K, Nakamura H, Kato Z, et al (2000) Biochemical and structural analysis of missense mutations in N-acetylgalactosamine-6-sulfate sulfatase causing mucopolysaccharidosis IVA phenotypes. Hum Mol Genet 22: 1283–1290.
Terzioglu M, Tokatli A, Coskun T, et al (2002) Molecular analysis of Turkish mucopolysaccharidosis IVA (Morquio A) patients: identification of novel mutations in the N-acetylgalactosamine-6-sulfate sulfatase (GALNS) gene. Hum Mutat 20: 477–478.
Tomatsu S, Fukuda S, Masue M, et al (1991) Morquio disease: isolation, characterization and expression of full-length cDNA for human N-acetylgalactosamine-6-sulfate sulfatase. Biochem Biophys Res Commun 181: 677–683.
Tomatsu S, Orii KO, Vogler C, et al (2003) Mouse model of N-acetylgalactosamine-6-sulfate sulfatase deficiency (Galns-/-) produced by targeted disruption of the gene defective in Morquio A disease. Hum Mol Genet 12: 3349–3358.
Tomatsu S, Montaño AM, Nishioka T, et al (2005a) Mutation and polymorphism spectrum of the GALNS gene in mucopolysaccharidosis IVA (Morquio A). Hum Mutat 26: 500–512.
Tomatsu S, Gutierrez M, Nishioka T, et al (2005b) Development of MPS IVA mouse (Galnstm(hC79S•mC76S)slu) tolerant to human N-acetylgalactosamine-6-sulfate sulfatase. Hum Mol Genet 14: 3321–3335.
Winkel LPF, Hagemans MLC, van Doorn PA, et al (2005) The natural course of non-classical Pompe's disease; a review of 225 published cases. J Neurol 252: 875–884.
Yamada N, Fukuda S, Tomatsu S, et al (1998) Molecular heterogeneity in mucopolysaccharidosis IVA in Australia and Northern Ireland: nine novel mutations including T312S, a common allele that confers a mild phenotype. Hum Mutat 11: 202–208.
Author information
Authors and Affiliations
Corresponding author
Additional information
Communicating editor: Verena Peters
Competing interests: None declared
References to electronic databases: MPS IVA, OMIM #253000
Rights and permissions
About this article
Cite this article
Montaño, A.M., Tomatsu, S., Gottesman, G.S. et al. International Morquio A Registry: Clinical manifestation and natural course of Morquio A disease. J Inherit Metab Dis 30, 165–174 (2007). https://doi.org/10.1007/s10545-007-0529-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10545-007-0529-7